SMG (The Scotts Miracle-Gro Company) Stock Analysis - News
The Scotts Miracle-Gro Company (SMG) is a publicly traded Basic Materials sector company. As of May 21, 2026, SMG trades at $58.38 with a market cap of $3.35B and a P/E ratio of 30.97. SMG moved +3.40% today. Year to date, SMG is -3.25%; over the trailing twelve months it is -7.19%. Its 52-week range spans $45.61 to $93.90. Analyst consensus is buy with an average price target of $72.80. Rallies surfaces SMG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in SMG news today?
Scotts Miracle-Gro Q2 Revenue Rises 5% to $1.46B; EPS $4.53 Beats Estimates: Scotts Miracle-Gro reported Q2 adjusted EPS of $4.53, beating estimates by $0.67, on revenue of $1.46B, up 5% year-over-year. Adjusted gross margin expanded 240 basis points to 41.8%, adjusted EBITDA rose 9% to $437.4M, and net leverage improved to 3.71x as the company reaffirmed full-year adjusted EPS guidance of $4.15-4.35.
Scotts Miracle-Gro Q2 Revenue Rises 5% to $1.46B; EPS $4.53 Beats Estimates: Scotts Miracle-Gro reported Q2 adjusted EPS of $4.53, beating estimates by $0.67, on revenue of $1.46B, up 5% year-over-year. Adjusted gross margin expanded 240 basis points to 41.8%, adjusted EBITDA rose 9% to $437.4M, and net leverage improved to 3.71x as the company reaffirmed full-year adjusted EPS guidance of $4.15-4.35.
Does Rallies summarize SMG news?
Yes. Rallies summarizes SMG news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SMG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SMG. It does not provide personalized investment advice.
